Metraipolis › archive › dc_5aa56ec96d37
Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer — Europe PMC PMID:41364261
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41364261
- DOI
- 10.1007/s10549-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T18:50:19.063Z
- SHA-256 of the archived text
d69960adc62fa7020a1a95e8f3d6ddc447178f8ba33bf84c1cba722f42302089- Stable URL of this page
https://metraipolis.com/documento/dc_5aa56ec96d37
How to cite
Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer — Europe PMC PMID:41364261 — Europe PMC (en), https://europepmc.org/article/MED/41364261 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5aa56ec96d37 (Metraipolis archive dc_5aa56ec96d37, sha256 d69960adc62fa7020a1a95e8f3d6ddc447178f8ba33bf84c1cba722f42302089)
BibTeX
@misc{dc5aa56ec96d37,
title = {Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer — Europe PMC PMID:41364261},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41364261},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5aa56ec96d37; sha256 d69960adc62fa7020a1a95e8f3d6ddc447178f8ba33bf84c1cba722f42302089},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41364261. Agents can read the archived copy with the MCP tool read_document.